Fractalkine and TGF-&beta;1 levels reflect the severity of chronic pancreatitis in humans

doi:10.3748/wjg.14.6488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3050)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

290

HTML

2496

Figures (1-7)

138

Tables (1-2)

126

Sum=3050

Nov 14, 2008 (publication date) through Jul 6, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Nov 14, 2008; 14(42): 6488-6495
Published online Nov 14, 2008. doi: 10.3748/wjg.14.6488

Full Size Figure Download Figure

Figure 1 Serum MCP-1, TGF-β1, and s-fractalkine concentrations in patients with CP. Serum MCP-1, TGF-β1, and s-fractalkine concentrations were measured by ELISA for each pancreatic disease. Healthy control (HC, n = 116) and chronic pancreatitis (CP, n = 109). Bars represent the mean ± SD. ^aP < 0.05 vs healthy control.

Citation: Yasuda M, Ito T, Oono T, Kawabe K, Kaku T, Igarashi H, Nakamura T, Takayanagi R. Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans. World J Gastroenterol 2008; 14(42): 6488-6495
URL: https://www.wjgnet.com/1007-9327/full/v14/i42/6488.htm
DOI: https://dx.doi.org/10.3748/wjg.14.6488